Skip to main content
Premium Trial:

Request an Annual Quote

University of Illinois

Premium
The University of Illinois has been awarded US Patent 7,445,888, “Methods for assaying for antidepressant therapy markers.”
 
The inventors listed on the patent are Mark Rasenick, Robert Donati, and Sadamu Toki.
 
The patent describes methods for assaying for agents that modify the association of Gs alpha with components of the plasma membrane or cytoskeleton of cells, according to its abstract. The patent also relates generally to methods of assaying for agents having antidepressant activity via analysis of the association of Gs alpha with components of the plasma membrane or cytoskeleton of cells using a fluorescent analog of Gs alpha and fluorescence resonance energy transfer.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.